- Home
- NTCT vs ZLAB Comparison
NTCT vs ZLAB Comparison
Compare NTCT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTCT | ZLAB |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1999 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NTCT | ZLAB |
|---|---|---|
| Price | $31.59 | $18.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $31.00 | ★ $49.60 |
| AVG Volume (30 Days) | 502.9K | ★ 707.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $891,820,000.00 | $460,156,000.00 |
| Revenue This Year | $6.02 | $14.46 |
| Revenue Next Year | $2.55 | $29.47 |
| P/E Ratio | $29.45 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $18.12 | $15.96 |
| 52 Week High | $32.87 | $44.34 |
Technical Indicators
Market Signals| Indicator | NTCT | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 50.77 |
| Support Level | $26.62 | $17.11 |
| Resistance Level | N/A | $19.49 |
| Average True Range (ATR) | 0.87 | 0.63 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 60.44 | 60.73 |
Price Performance
Historical ComparisonAbout NTCT NetScout Systems Inc.
NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.